Skip to main navigation Skip to search Skip to main content

Therapeutic Potential of Exosomes Derived from Diabetic Adipose Stem Cells in CutaneousWound Healing of db/db Mice

  • Hsiang Hao Hsu
  • , Aline Yen Ling Wang
  • , Charles Yuen Yung Loh
  • , Ashwin Alke Pai
  • , Huang Kai Kao*
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital
  • Cambridge University Hospitals NHS Foundation Trust
  • Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

56 Scopus citations

Abstract

(1) Background: Diabetes impairs angiogenesis and wound healing. Paracrine secretion from adipose stem cells (ASCs) contains membrane-bound nano-vesicles called exosomes (ASC-Exo) but the functional role and therapeutic potential of diabetic ASC-Exo in wound healing are unknown. This study aims to investigate the in vivo mechanistic basis by which diabetic ASC-Exo enhance cutaneous wound healing in a diabetic mouse model. (2) Methods: Topically applied exosomes could efficiently target and preferentially accumulate in wound tissue, and the cellular origin, ASC or dermal fibroblast (DFb), has no influence on the biodistribution pattern of exosomes. In vivo, full-thickness wounds in diabetic mice were treated either with ASC-Exo, DFb-Exo, or phosphatebuffered saline (PBS) topically. ASC-Exo stimulated wound healing by dermal cell proliferation, keratinocyte proliferation, and angiogenesis compared with DFb-Exo and PBS-treated wounds. (3) Results: Diabetic ASC-Exo stimulated resident monocytes/macrophages to secrete more TGF- _1 and activate the TGF-_/Smad3 signaling pathway. Fibroblasts activated by TGF-_1containing exosomes from ASCs initiate the production of TGF-_1 protein in an autocrine fashion, which leads to more proliferation and activation of fibroblasts. TGF-_1 is centrally involved in diabetic ASCExo mediated cellular crosstalk as an important early response to initiating wound regeneration. (4) Conclusions: The application of diabetic ASC-Exo informs the potential utility of a cell free therapy in diabetic wound healing.

Original languageEnglish
Article number1206
JournalPharmaceutics
Volume14
Issue number6
DOIs
StatePublished - 06 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adipose stem cell
  • Cutaneous wound healing
  • Exosomes

Fingerprint

Dive into the research topics of 'Therapeutic Potential of Exosomes Derived from Diabetic Adipose Stem Cells in CutaneousWound Healing of db/db Mice'. Together they form a unique fingerprint.

Cite this